Patents by Inventor Myung Won JIN

Myung Won JIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CASPASE INHIBITOR FOR ALLEVIATING OR TREATING OSTEOARTHRITIS
    Publication number: 20230310412
    Abstract: The present invention relates to a use of a caspase inhibitor for alleviating or treating osteoarthritis.
    Type: Application
    Filed: August 4, 2021
    Publication date: October 5, 2023
    Applicant: LG CHEM, LTD.
    Inventors: Jae Uk BAEK, Jung Gyu PARK, Sung Won KIM, Hyun Seo PARK, Sei Hyun CHOI, Myung Won JIN, Min Kyoung LEE
  • FUSION POLYPEPTIDE COMPRISING GDF15 AND POLYPEPTIDE REGION CAPABLE OF O-GLYCOSYLATION
    Publication number: 20230133672
    Abstract: Disclosed are: a fusion polypeptide comprising growth differentiation factor 15 (GDF15) and a polypeptide region capable of O-glycosylation; a pharmaceutical composition comprising the fusion polypeptide; and a method for increasing the in vivo duration of GDF15, comprising the step of fusing a polypeptide region capable of O-glycosylation.
    Type: Application
    Filed: December 10, 2020
    Publication date: May 4, 2023
    Applicant: LG CHEM, LTD.
    Inventors: Yeonchul KIM, Young Dok SON, Kyubong NA, Ji Ho HONG, Saem JUNG, Myung Won JIN, Ji A PARK, Soomin NOH, Hyuntaek PARK
  • FUSION POLYPEPTIDE COMPRISING Fc REGION OF IMMUNOGLOBULIN AND GDF15
    Publication number: 20230053119
    Abstract: Provided is a fusion polypeptide comprising GDF15 (Growth/differentiation factor 15) and an Fc region of immunoglobulin, a pharmaceutical composition comprising the fusion polypeptide, and a method of increasing in vivo duration of GDF15 comprising fusing with an Fc region of immunoglobulin.
    Type: Application
    Filed: April 22, 2020
    Publication date: February 16, 2023
    Applicant: LG CHEM, LTD.
    Inventors: Yeonchul KIM, Kyeongsik MIN, Young Dok SON, Kyubong NA, Ji Ho HONG, Saem JUNG, Myung Won JIN, Ji A PARK, Soomin NOH
  • INJECTABLE COMPOSITION CONTAINING PRODRUG OF CASPASE INHIBITORS, AND PREPARATION METHOD THEREFOR
    Publication number: 20220226234
    Abstract: The present invention relates to an injectable pharmaceutical composition containing a prodrug of caspase inhibitors, and a preparation method therefor. More specifically, the present invention relates to an injectable pharmaceutical composition, and a preparation method therefor, the composition comprising, as an active ingredient, (2S,3S)-2-(fluoromethyl)-3-((R)-5-isopropyl-3-(isoquinolin-1-yl)-4,5-dihydroisoxazole-5-carboxamido)-5-oxotetrahydrofuran-2-yl acetate, which is a prodrug of caspase inhibitors, or a pharmaceutically acceptable salt or isomer thereof, and comprising, as a biocompatible polymer, microspheres containing poly(lactide-co-glycolide).
    Type: Application
    Filed: May 29, 2020
    Publication date: July 21, 2022
    Applicant: LG CHEM, LTD.
    Inventors: Sung Won KIM, Jae Uk BAEK, Hyun Seo PARK, Myung Won JIN, Jung Gyu PARK, Bok Tae KIM, Sei Hyun CHOI